---
$id: https://graph.org.ai/products/commodity/51111636
$type: Product
source: UNSPSC
code: "51111636"
title: "Enocitabine"
class: "51111600"
classTitle: "Antimetabolites"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Enocitabine

**UNSPSC Code**: 51111636
**Class**: [Antimetabolites](Antimetabolites.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a pyrimidine antagonist with the molecular formula C31H55N3O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9YVR68W306, chemically known as docosanamide,nucleoside deriv but generally known as enocitabine, which bears US NIH Compound Identifier 3228. European Medicines Agency schedules Enocitabine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06537MIG. The term ENOCITABINE is an International Non-Proprietary Name. ENOCITABINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule enocitabine under HS 29349990 and SITC 51579. As of Q4 2014, ENOCITABINE remains the US FDA Preferred Term for this commodity. Enocitabine bears US NLM identifiers UMLS ID C0059364 and NCI Concept Code C1082. SMILES: O1C(C(O)C(O)C1N1CCC(NC1=O)NC(=O)CCCCCCCCCCCCCCCCCCCCC)CO.

